SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 12, 2014	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-14-409363.pdf 0001193125-14-409363.rtf 0001193125-14-409363.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Oct 30, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-388279.pdf 0001193125-14-388279.rtf 0001193125-14-388279.xls
Oct 02, 2014		D	View HTML 0001427570-14-000001.pdf 0001427570-14-000001.rtf 0001427570-14-000001.xls
Oct 01, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-360877.pdf 0001193125-14-360877.rtf 0001193125-14-360877.xls
Aug 08, 2014	Quarterly report which provides a continuing view of a company's financial position	10-Q	View HTML 0001193125-14-303089.pdf 0001193125-14-303089.rtf 0001193125-14-303089.xls EX-101.INS - XBRL INSTANCE DOCUMENT
Aug 07, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-299459.pdf 0001193125-14-299459.rtf 0001193125-14-299459.xls
Jun 25, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-249333.pdf 0001193125-14-249333.rtf 0001193125-14-249333.xls
Jun 20, 2014	Statement of changes in beneficial ownership of securities	4	View HTML 0001181431-14-024606.pdf 0001181431-14-024606.rtf
Jun 20, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-243928.pdf 0001193125-14-243928.rtf 0001193125-14-243928.xls
Jun 18, 2014	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-14-239469.pdf 0001193125-14-239469.rtf 0001193125-14-239469.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE